These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37336)
1. Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities. Nagai Y; Irie A; Masuda Y; Oka M; Uno H J Med Chem; 1979 Jun; 22(6):677-83. PubMed ID: 37336 [TBL] [Abstract][Full Text] [Related]
2. 4a,9b-trans-8-Fluoro-5-(4-fluorophenyl)-2-[4-(4-fluorophenyl)-4-hydroxybutyl]-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole hydrochloride, a new potent neuroleptic. Welch WM; Ewing FE; Harbert CA; Weissman A; Koe BK J Med Chem; 1980 Aug; 23(8):949-52. PubMed ID: 6105220 [TBL] [Abstract][Full Text] [Related]
3. Neuroleptics from the 4a,9b-cis- and 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 2. Welch WM; Harbert CA; Weissman A; Koe BK J Med Chem; 1986 Oct; 29(10):2093-9. PubMed ID: 2876102 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptics from the 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 3. Carboxamidoalkyl derivatives. Welch WM; Harbert CA; Sarges R; Weissman A; Koe BK J Med Chem; 1986 Oct; 29(10):2108-11. PubMed ID: 2876105 [TBL] [Abstract][Full Text] [Related]
5. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity. Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines. Sarges R; Howard HR; Donahue KM; Welch WM; Dominy BW; Weissman A; Koe BK; Bordner J J Med Chem; 1986 Jan; 29(1):8-19. PubMed ID: 3941416 [TBL] [Abstract][Full Text] [Related]
7. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents. Norman MH; Rigdon GC; Navas F; Cooper BR J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539 [TBL] [Abstract][Full Text] [Related]
8. Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI. Fink-Jensen A; Nielsen EB; Hansen L; Scheideler MA Eur J Pharmacol; 1998 Jan; 342(2-3):153-61. PubMed ID: 9548380 [TBL] [Abstract][Full Text] [Related]
9. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives. Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects. Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833 [No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability. Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922 [TBL] [Abstract][Full Text] [Related]
12. 2,3,4,4a,5,9b-Hexahydro-1H-indeno[1,2-b]pyridines: potential antidepressants. Kunstmann R; Lerch U; Gerhards H; Leven M; Schacht U J Med Chem; 1984 Apr; 27(4):432-9. PubMed ID: 6708046 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions. Hirose A; Kato T; Ohno Y; Shimizu H; Tanaka H; Nakamura M; Katsube J Jpn J Pharmacol; 1990 Jul; 53(3):321-9. PubMed ID: 1975278 [TBL] [Abstract][Full Text] [Related]
14. 5-Piperazinylalkyl-2(3H)-oxazolones with neuroleptic activity. Cascio G; Manghisi E; Fregnan G J Med Chem; 1989 Oct; 32(10):2241-7. PubMed ID: 2571727 [TBL] [Abstract][Full Text] [Related]
15. Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds. Ishizumi K; Kojima A; Antoku F; Saji I; Yoshigi M Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2139-51. PubMed ID: 8582016 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity. Chakrabarti JK; Hotten TM; Pullar IA; Steggles DJ J Med Chem; 1989 Oct; 32(10):2375-81. PubMed ID: 2571731 [TBL] [Abstract][Full Text] [Related]
17. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives. Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538 [TBL] [Abstract][Full Text] [Related]
18. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist. Bartoszyk GD; Harting J; Minck KO J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents. Hrib NJ; Jurcak JG; Huger FP; Errico CL; Dunn RW J Med Chem; 1991 Mar; 34(3):1068-72. PubMed ID: 1672156 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic activity of substituted gamma-carbolines. Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA J Med Chem; 1987 Oct; 30(10):1818-23. PubMed ID: 2888898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]